Biotech Week Boston highlights research progress in cell and gene therapy

By Samantha Black, PhD, ScienceBoard editor in chief

At Biotech Week Boston, ScienceBoard.net spoke with experts in cell and gene therapy technologies.

Biotech Week Boston is a collection of several industry-leading events, including BioProcess International, Cell & Gene Therapy Manufacturing & Commercialization US, and TIDES USA. The event was held at the Boston Convention Center from September 21-23. In attendance were life science professionals with expertise in discovery, financing, manufacturing, and clinical trials.

Video loading ...

We caught up with the following experts:

  • Stefano Menegatti, associate professor at North Carolina State University
  • Armon Sharei, founder and CEO of SQZ Biotech
  • Fabian Gerlinghaus, co-founder and CEO of Cellares
  • Andrew Tustian, director of viral process development at Regeneron Pharmaceuticals

High-throughput analysis speeds downstream process development
Adding high-throughput analysis helped speed up downstream process development for drug candidates based on monoclonal antibodies, according to a case...
Optofluidics aids cell line development for antibody-based therapies
Implementation of optofluidics in cell line development can help advance multiple lead candidate molecules with increased screening capacity. A researcher...

Copyright © 2021 scienceboard.net


Conferences
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter